SEC Form 4 · accession 0000899243-15-008521
EndoChoice Holdings, Inc. · GI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Uri Geiger
Director
Period of report
Nov 17, 2015
Accepted (ET)
Nov 19, 2015 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1 | Nov 17, 2015 | D | 5,625 | $0.00 | D | 0 | D | |
| Common stock, par value $0.001 per shareF2 | Nov 17, 2015 | A | 5,625 | $0.00 | A | 5,625 | I | By ESOP Management Trust Services Ltd. for the benefit of Uri Geiger |
| Common stock, par value $0.001 per shareF3 | holding | — | — | — | 2,284,989 | I | By ESOP Management and Trust Services Ltd. for the benefit of U.M. Accelmed or related entities |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On November 11, 2015, the Company and Dr. Geiger agreed to rescind the 5,625 shares of restricted common stock initially granted to Dr. Geiger on August 14, 2015 under the EndoChoice Holdings, Inc. 2015 Omnibus Equity Incentive Plan. This rescission is effective as of August 14, 2015, the date that the shares of restricted common stock were originally granted to Dr. Geiger.
- F2Represents shares of restricted common stock vesting on the earlier of August 14, 2016 and Dr. Greiger's departure from the Company's board of directors.
- F3The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.